Involvement of phosphatidylinositol-3 kinase/AKT/PKCζ/λ pathway in the effect of palmitate on glucose-induced insulin secretion

Pancreas

Volumn 37, Issue 3, 2008, Pages 309-315

  Nogueira, Tatiane C A ^a   Anhê, Gabriel F ^a   Carvalho, Carla R O ^a   Curi, Rui ^a   Bordin, Silvana ^a   Carpinelli, Angelo R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ceramide; Insulin secretion; Palmitate; Pancreatic islets; PI3K signaling

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CERAMIDE; FUMONISIN B1; GLUCOSE; INSULIN; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C ZETA; WORTMANNIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANDROSTANE DERIVATIVE; CHAPERONE; CHROMONE DERIVATIVE; FUMONISIN; ISOENZYME; MORPHOLINE DERIVATIVE; PRKCZ PROTEIN, RAT; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; IMMUNOBLOTTING; INSULIN RELEASE; LIPOGENESIS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; METABOLISM; PANCREAS ISLET; PHOSPHORYLATION; SECRETION; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; CERAMIDES; CHROMONES; FEMALE; FUMONISINS; GLUCOSE; INSULIN; ISLETS OF LANGERHANS; ISOENZYMES; MOLECULAR CHAPERONES; MORPHOLINES; PALMITIC ACID; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 58149333763     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpa.0b013e318168dac3     Document Type: Article

References (54)

1. Thorens B, Sarkar HK, Kaback HR, et al. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell. 1988;55(2): 281-290.
2. Matschinsky FM. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 1996;45(2):223-241.
3. Malaisse WJ. Insulin secretion: multifactorial regulation for a single process of release. The Minkowski award lecture delivered on September 7, 1972 before the European Association for the study of Diabetes at Madrid, Spain. Diabetologia. 1973;9(3):167-173.
4. Bollheimer LC, Skelly RH, Chester MW, et al. Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest. 1998; 101(5):1094-1101.
5. Warnotte C, Gilon P, Nenquin M, et al. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes. 1994;43(5):703-711.
6. Carpinelli AR, Picinato MC, Stevanato E, et al. Insulin secretion induced by palmitate - a process fully dependent on glucose concentration. Diabetes Metab. 2002;28(6):3S37-3S44. discussion 3S108-3S112.
7. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992;258(5083):766-770.
8. Ö stenson CG, Chen J, Sheu L, et al. Effects of palmitate on insulin secretion and exocytotic proteins in islets of diabetic Goto-Kakizaki rats. Pancreas. 2007;34(3):359-363.
9. Itoh Y, Kawamata Y, Harada M, et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature. 2003; 422:173-176.
10. Briscoe CP, Tadayyon M, Andrews JL, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003;278(13):11303-11311.
11. Itoh Y, Hinuma S. GPR40, a free fatty acid receptor on pancreatic beta cells, regulates insulin secretion. Hepatol Res. 2005;33(2):171-173.
12. Latour MG, Alquier T, Oseid E, et al. GPR40 is necessary but not sufficient for fatty acid stimulation of insulin secretion in vivo. Diabetes. 2007;56(4):1087-1094.
13. Aspinwall CA, Qian WJ, Roper MG, et al. Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in beta-cells. J Biol Chem. 2000;275(29):22331-22338.
14. 2+ and insulin secretion from pancreatic beta cells. Diabetes. 2002;51(Suppl 1):S43-S49.
15. Kulkarni RN. Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Biochem Soc Trans. 2002;30(2):317-322.
16. Zawalich WS, Tesz GJ, Zawalich KC. Inhibitors of phosphatidylinositol 3-kinase amplify insulin release from islets of lean but not obese mice. J Endocrinol. 2002;174(2):247-258.
17. Khan FA, Goforth PB, Zhang M, et al. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes. 2001;50(10):2192-2198.
18. Haber EP, Hirabara SM, Gomes AD, et al. Palmitate modulates the early steps of insulin signalling pathway in pancreatic islets. FEBS Lett. 2003;544(1-3):185-188.
19. Prentki M, Vischer S, Glennon MC, et al. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J Biol Chem. 1992;267:5802-5810.
20. Roduit R, Nolan C, Alarcon C, et al. A role for the malonyl-CoA/ longchain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. Diabetes. 2004;53(4):1007-1019.
21. Kelpe CL, Moore PC, Parazzoli SD, et al. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem. 2003;278(32):30015-30021.
22. Merrill AH Jr, Schmelz EM, Dillehay DL, et al. Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol. 1997;142(1):208-225.
23. Salinas M, Lopez-Valdaliso R, Martin D, et al. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol Cell Neurosci. 2000;15(2):156-169.
24. Kralik SF, Liu P, Leffler BJ, et al. Ceramide and glucosamine antagonism of alternate signaling pathways regulating insulin- and osmotic shock-induced glucose transporter 4 translocation. Endocrinology. 2002;143(1):37-46.
25. Carpinelli AR, Curi R, Malaisse WJ. Long-term regulation of pancreatic B-cell responsiveness to D-glucose by food availability, feeding schedule, and diet composition. Physiol Behav. 1992;52:1193-1196.
26. Scott AM, Atwater I, Rojas E. A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia. 1981;21(5):470-475.
27. Conget I, Rasschaert J, Sener A, et al. Secretory, biosynthetic, respiratory, cationic, and metabolic responses of pancreatic islets to palmitate and oleate. Biochem Med Metab Biol. 1994;51:175-184.
28. Warnotte C, Gilon P, Nenquin M, et al. Mechanism of the stimulation of insulin release by saturated fatty acids. Diabetes. 1994;43:703-711.
29. Haber EP, Procopio J, Carvalho CR, et al. New insights into fatty acid modulation of pancreatic beta-cell function. Int Rev Cytol. 2006; 248:1-41.
30. Steneberg P, Rubins N, Bartoov-Shifman R, et al. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 2005;1(4):245-258.
31. Littman ED, Pitchumoni S, Garfinkel MR, et al. Role of protein kinase C isoenzymes in fatty acid stimulation of insulin secretion. Pancreas. 2000;20(3):256-263.
32. Yaney GC, Corkey BE. Fatty acid metabolism and insulin secretion in pancreatic beta cells. Diabetologia. 2003;46(10):1297-1312.
33. Aspinwall CA, Lakey JR, Kennedy RT. Insulin-stimulated insulin secretion in single pancreatic beta cells. J Biol Chem. 1999;274(10): 6360-6365.
34. Araújo EP, Amaral ME, Souza CT, et al. Blockade of IRS1 in isolated rat pancreatic islets improves glucose-induced insulin secretion. FEBS Lett. 2002;531:437-442.
35. Verspohl EJ, Ammon HP. Evidence for presence of insulin receptors in rat islets of Langerhans. J Clin Invest. 1980;65(5):1230-1237.
36. Velloso LA, Carneiro EM, Crepaldi SC, et al. Glucose- and insulin-induced phosphorylation of the insulin receptor and its primary substrates IRS-1 and IRS-2 in rat pancreatic islets. FEBS Lett. 1995;377(3):353-357.
37. Alter CA, Wolf BA. Identification of phosphatidylinositol 3,4,5-trisphosphate in pancreatic islets and insulin-secreting-cells. Biochem Biophys Res Commun. 1995;208(1):190-197.
38. Holst LS, Mulder H, Manganiello V, et al. Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochem Biophys Res Commun. 1998;250(1):181-186.
39. Zawalich WS, Zawalich KC. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from the islets of lean, but not obese, rats. Endocrinology. 2000;14:3287-3295.
40. Rouzaire-Dubois B, Gerard V, Dubois JM. Involvement of K+ channels in the quercetin-induced inhibition of neuroblastoma cell growth. Pflugers Arch. 1993;423:202-205.
41. El-Kholy W, Macdonald PE, Lin JH, et al. The phosphatidylinositol 3-kinase inhibitor LY294002 potently blocks K(V) currents via a direct mechanism. FASEB J. 2003;17(6):720-722.
42. Toker A, Meyer M, Reddy KK, et al. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem. 1994;269:32358-32367.
43. Wrede CE, Dickson LM, Lingohr MK, et al. Fatty acid and phorbol ester-mediated interference of mitogenic signaling via novel protein kinase C isoforms in pancreatic beta-cells (INS-1). J Mol Endocrinol. 2003;30:271-286.
44. Toker A, Newton AC. Cellular signaling: pivoting around PDK-1. Cell. 2000;103:185-188.
45. Stratford S, DeWald DB, Summers SA. Ceramide dissociates 3'- phosphoinositide production from pleckstrin homology domain translocation. Biochem J. 2001;354:359-368.
46. Soltys CL, Buchholz L, Gandhi M, et al. Phosphorylation of cardiac protein kinase B is regulated by palmitate. Am J Physiol Heart Circ Physiol. 2002;283:H1056-H1064.
47. Kim YI, Lee FN, Choi WS, et al. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes. 2006;55(8):2311-2317.
48. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science. 1996;274(5294):1855-1859.
49. Sabin MA, Stewart CE, Crowne EC, et al. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid. J Cell Physiol. 2007;211(1):244-252.
50. Chavez JA, Holland WL, Bär J, et al. Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling. J Biol Chem. 2005;280(20):20148-20153.
51. Stratford S, Hoehn KL, Liu F, et al. Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B. J Biol Chem. 2004;279(35): 36608-36615.
52. Miura A, Kajita K, Ishizawa M, et al. Inhibitory effect of ceramide on insulin-induced protein kinase Czeta translocation in rat adipocytes. Metabolism. 2003;52(1):19-24.
53. Moore PC, Ugas MA, Hagman DK, et al. Evidence against the involvement of oxidative stress in fatty acid inhibition of insulin secretion. Diabetes. 2004;53(10):2610-2616.
54. Sjöholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett. 1995;367(3):283-286.